Cynthia Collins Insider Trading $EDIT Editas Medicine, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Cynthia Collins.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Cynthia Collins. Cynthia Collins is Group Vice President in BECKMAN COULTER INC ($BEC) and CEO in Editas Medicine, Inc. ($EDIT) and Director in Editas Medicine, Inc. ($EDIT) and Interim CEO in Editas Medicine, Inc. ($EDIT) and Director in DermTech, Inc. ($CNACU).
Cynthia Collins in Editas Medicine, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Cynthia Collins: Interim CEO, Director
Holdings: 43,760 shares
Current Value: $812,186
Latest Transaction: Feb 10 2021
$EDIT Market Capitalization: $636.78M
$EDIT Previous Close: $18.56
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Cynthia Collins in Editas Medicine, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BEC, DMTK, EDIT
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 10 2021 | EDIT | Editas Medicine, I ... | Collins Cynthia | CEO | Sell | S | 66.65 | 1,262 | 84,112 | 43,760 | 45 K to 43.8 K (-2.80 %) |
| Aug 21 2020 | EDIT | Editas Medicine, I ... | Collins Cynthia | CEO | Sell | S | 36.66 | 1,976 | 72,440 | 45,022 | 47 K to 45 K (-4.20 %) |
| Feb 10 2020 | EDIT | Editas Medicine, I ... | Collins Cynthia | CEO | Option Exercise | A | 28.05 | 93,750 | 2,629,688 | 93,750 | |
| Feb 10 2020 | EDIT | Editas Medicine, I ... | Collins Cynthia | CEO | Grant | A | 0.00 | 15,625 | 0 | 46,998 | 31.4 K to 47 K (+49.80 %) |
| Sep 13 2019 | EDIT | Editas Medicine, I ... | Collins Cynthia | CEO | Option Exercise | A | 26.57 | 250,000 | 6,642,500 | 250,000 | |
| Sep 13 2019 | EDIT | Editas Medicine, I ... | Collins Cynthia | CEO | Option Exercise | A | 26.57 | 500,000 | 13,285,000 | 500,000 | |
| Sep 13 2019 | EDIT | Editas Medicine, I ... | Collins Cynthia | CEO | Grant | A | 0.00 | 20,000 | 0 | 31,373 | 11.4 K to 31.4 K (+175.86 %) |
| Aug 21 2019 | EDIT | Editas Medicine, I ... | Collins Cynthia | CEO | Sell | S | 25.83 | 5,193 | 134,135 | 11,373 | 16.6 K to 11.4 K (-31.35 %) |
| Aug 21 2019 | EDIT | Editas Medicine, I ... | Collins Cynthia | CEO | Grant | A | 0.00 | 8,283 | 0 | 16,566 | 8.3 K to 16.6 K (+100.00 %) |
| Aug 07 2019 | EDIT | Editas Medicine, I ... | Collins Cynthia | CEO | Grant | A | 0.00 | 8,283 | 0 | 16,566 | 8.3 K to 16.6 K (+100.00 %) |
| Jun 14 2019 | EDIT | Editas Medicine, I ... | Collins Cynthia | Interim CEO | Option Exercise | A | 21.74 | 11,538 | 250,836 | 11,538 | |
| Feb 04 2019 | EDIT | Editas Medicine, I ... | Collins Cynthia | Director | Option Exercise | A | 0.00 | 8,283 | 0 | 8,283 | |
| Dec 10 2018 | EDIT | Editas Medicine, I ... | Collins Cynthia | Director | Option Exercise | A | 29.69 | 23,076 | 685,126 | 23,076 |
Page: 1